CRP and COVID-19: Shah and colleagues reported a significant reduction of SDNN and rMSSD in women and men recently recovered from COVID-19 (30–45 days after an acute infection) and suggested that alterations of rMSSD were inversely correlated to inflammatory markers CRP and interleukin-615.